Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
Business Wire6d
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
Yahoo Finance4mon
Gossamer Bio, Inc. (GOSS)
Register for the Conference here. Submit Questions for any of the presenting com SAN DIEGO, February 03, 2025--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused ...